AzTrials
AzTrials

Mandible FractureSMRPNCT07221916

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up

An observational study of Mandible Fracture and Mandibular Reconstruction, run by Stryker Craniomaxillofacial at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A retrospective post market follow up to confirm safety and performance of Stryker's Surgeon iD Plates (SMRP) medical device. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use. Read more about this study

Who is it for?
Any age
Conditions the study is for
Mandible Fracture, Mandibular Reconstruction
What is being tested?
Mandibular Reconstruction
Type of treatment
Medical device
How many people
70 participants
Where
2 sitesin 2 countries
Study dates
1 Dec 2024to 27 Feb 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Eligible patients will be identified as having had a surgical procedure involving the Subject Device.

Who may be able to join

  • Patients who underwent primary or secondary mandibular reconstruction using a Stryker Surgeon iD Plate implant as per routine clinical practice.
  • Patients for whom data on the primary outcome variable is available.

Who cannot join

  • Patients with active local infections at the time of surgery.
  • Patients with known metal allergies and/or foreign body sensitivity at the time of surgery.
  • Potentially non-compliant patients who were unwilling or incapable of following post-operative care instructions.
  • Patients with inadequate bone quantity or quality necessary for plate fixation or stabilization at the time of surgery

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

United States1 site
  • UCSF Otolaryngology Head and Neck Surgery

    San Francisco, California, 94143

Other trials in United States

Germany1 site
  • Heinrich-Braun-Klinikum gGmbH

    Zwickau, 08060

Other trials in Germany

About this study

Official title: Stryker Customized Plates for Mandibular Reconstruction: A Retrospective Post Market Follow Up to Confirm Safety and Performance of Surgeon iD Mandible Reconstruction Plates

A retrospective post market follow up to confirm safety and performance of Stryker's Surgeon iD Plates (SMRP) medical device. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Read the detailed description

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker's Surgeon iD Mandible Recon Plate when used in the clinical setting. This study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively.

Based on a non-inferiority study power calculation a minimum of 27 patients will be enrolled in the study. Additional patients may be enrolled up to 80 subjects depending on site enrolment rate and patient availability. Up to 3 investigational sites within the United States and one in the EU will participate in this study. The primary outcome parameter evaluating successful reconstruction of the mandible without the need for unplanned revision surgery will be assessed at all available follow-up timepoints for included patients.

Being tested
Mandibular Reconstruction
Medical subject headings
Mandibular Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mandibular ReconstructionDevice

    Also called Mandibular Fracture Fixation

    Mandibular Reconstruction or mandibular fracture fixation using a Surgeon iD Mandible Reconstruction Plate (referred to as Surgeon iD Plates).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of successful reconstruction of the mandible without the need for unplanned revision surgery compared to benchmark devices in scientific literature.

    Rate of unplanned revision surgery determined by reviewing adverse events in patient medical charts after surgery. Used to document whether an unplanned revision surgery was required or not for each patient.

    Measured: Data collected at a single time point per patient in the course of 12 months

Secondary outcomes (13)
  1. Infection rate

    Determined by adverse events reported from patient medical charts.

    Measured: Data collected at time points from patient medical charts in the course of 12 months.

  2. Intraoperative complications

    Determined by adverse events reported from patient medical charts.

    Measured: Data collected at a single time point per patient in the course of 12 months.

  3. Postoperative complications

    Determined by adverse events reported from patient medical charts.

    Measured: Data collected at time points per patient in the course of 12 months.

  4. Any known adverse events

    Determined by adverse events reported from patient medical charts.

    Measured: Data collected at time points per patient in the course of 12 months.

  5. Rate of Plate failure

    Determined by adverse events reported from patient medical charts.

    Measured: Data collected at time points per patient in the course of 12 months.

  6. Operating room (OR) time

    Time patients are operated (hh:mm)

    Measured: Data collected at a single time point per patient in the course of 12 months.

  7. Time to return to solid food/normal diet

    Time for patient to return to solid food/normal diet post operation (dd)

    Measured: Data collected at a single time point per patient in the course of 12 months.

  8. Rate of satisfactory occlusion achieved with orthodontic treatment.

    Assessed by review of individual patient medical records that document the rate of satisfactory occlusion achieved with orthodontic treatment.

    Measured: Data collected at time points per patient in the course of 12 months.

  9. Hospitalization time: ICU and normal ward

    Time the patient was hospitalized post procedure (dd:hh)

    Measured: Data collected at a single time point per patient in the course of 12 months.

  10. Short-form-12-health-survey-questionnaire (if available)

    Short-form-12-health-survey-Questionnaire (Scale of 0-100. Scores above 50 indicate a better-than-average health-related quality of life, while scores below 50 suggest below-average health).

    Measured: Data collected at time points per patient in the course of 12 months.

  11. Ischemia time

    Ischemia time (dd:hh)

    Measured: Data collected at a single time point per patient in the course of 12 months.

  12. EuroQol-5 Domain Questionnaire (if available)

    A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).

    Measured: Data collected at time points per patient in the course of 12 months.

  13. Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)

    40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.

    Measured: Data collected at time points per patient in the course of 12 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2025
  2. Study start1 Dec 2024
  3. Primary completion27 Feb 2026
  4. Study completion27 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07221916
Sponsor's protocol ID
Surgeon iD Plates _2023_01
Acronym
SMRP
Status last verified
Apr 2026
First submitted
31 Jul 2025
Last updated
22 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mandible Fracture and Mandibular Reconstruction, run by Stryker Craniomaxillofacial at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of successful reconstruction of the mandible without the need for unplanned revision surgery compared to benchmark devices in scientific literature. (time frame: Data collected at a single time point per patient in the course of 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in